Household Product Labeling Act of 2009

H.R.317 - To amend the Securities Exchange Act of 1934 to prohibit the Securities and Exchange Commission from requiring an issuer to make climate-related disclosures that are not material to investors, and for other purposes. (Stephanie Bice, R-OK-5) H.R.557 - To promote United States interests at the international financial institutions, and for other purposes. (French Hill, R-AR-2) S.391 - A bill to amend the Securities Exchange Act of 1934 to prohibit the Securities and Exchange Commission from requiring an issuer to disclose information relating to certain greenhouse gas emissions, and for other purposes. (John Boozman, R-AR) House Version: H.R.1018 - To amend the Securities Exchange Act of 1934 to prohibit the Securities and Exchange Commission from requiring an issuer to disclose information related to certain greenhouse gas emissions, and for other purposes. (Frank Lucas, R-OK-3) H.R.1165 - Data Privacy Act of 2023 (Patrick McHenry, R-NC-10) H.R.1313 - To enhance rulemaking requirements for the Bureau of Consumer Financial Protection, and for other purposes. (Alex Mooney, R-WV-2) H.R.1382 - To change the Bureau of Consumer Financial Protection into an independent agency named the Consumer Financial Empowerment Agency, to transition the Agency to the regular appropriations process, and for other purposes. (Andy Barr, R-KY-6) H.R.1410 - To amend the Consumer Financial Protection Act of 2010 to make the Bureau of Consumer Financial Protection an independent Consumer Financial Protection Commission, and for other purposes. (Blaine Luetkemeyer, R-MO-3) H.R.1411 - To require Senate confirmation of Inspector General of the Bureau of Consumer Financial Protection, and for other purposes. (Blaine Luetkemeyer, R-MO-3) H.R.1506 - To amend section 1003 of title 5, United States Code (commonly referred to as the Federal Advisory Committee Act), to prohibit the establishment of advisory committees related to environmental, social, and governance aspects. (Ronny Jackson, R-TX-13) S.915 - A bill to require Presidential appointment and Senate confirmation of the Inspector General of the Board of Governors of the Federal Reserve System and the Bureau of Consumer Financial Protection. (Rick Scott, R-FL) S.1160 - A bill to provide greater transparency with respect to the financial regulatory agencies, and for other purposes. (Thom Tillis, R-NC) H.R.2489 - To amend the Consumer Financial Protection Act of 2010 to update the purpose of the Bureau of Consumer Financial Protection, and for other purposes. (Tom Emmer, R-MN-6) H.R.2798 - CFPB Transparency and Accountability Reform Act (Andy Barr, R-KY-6) H.R.2937 - To eliminate the Bureau of Consumer Financial Protection. (Byron Donalds, R-FL-19) Senate Version: S.1363 - A bill to eliminate the Bureau of Consumer Financial Protection. (Ted Cruz, R-TX) H.R.3057 - To provide that under the securities laws certain disclosures related to scope 3 greenhouse-gas emissions may not be required. (Ronny Jackson, R-TX-13) S.1362 - A bill to amend the Consumer Financial Protection Act of 2010 to enhance rulemaking requirements for the Bureau of Consumer Financial Protection, and for other purposes. (John Kennedy, R-LA) H.R.3466 - To enhance Financial Stability Oversight Council transparency. (Andy Barr, R-KY-6) H.R.3812 - To amend the Financial Stability Act of 2010 to require the Financial Stability Oversight Council to consider alternative approaches before determining that a U.S. nonbank financial company shall be supervised by the Board of Governors of the Federal Reserve System, and for other purposes. (Bill Foster, D-IL-11) H.R.4206 - To amend the Financial Stability Act of 2010 to require covered financial institutions to include elements of accumulated other comprehensive income when calculating capital for purposes of meeting capital requirements, and for other purposes. (Brad Sherman, D-CA-32) H.R.4642 - To require transparency from the Federal financial regulators with respect to international meetings, negotiations, and agreements, and for other purposes. (Mike Flood, R-NE-1) S.2409 - A bill to limit purchases of the Federal reserve banks, to require Generally Accepted Accounting Principles standards, and for other purposes. (Rick Scott, R-FL) H.R.5993 - To amend the Consumer Financial Protection Act of 2010 to clarify the funding of the Bureau of Consumer Financial Protection, and for other purposes. (French Hill, R-AR-2) Senate Version: S.3095 - A bill to amend the Consumer Financial Protection Act of 2010 to clarify the funding of the Bureau of Consumer Financial Protection. (Bill Hagerty, R-TN) H.R.6486 - To establish the position of Coordinator for Community Financial Institutions within the Small Business Administration to enhance the performance of community financial institutions and support access to capital for small business concerns, and for other purposes. (Morgan McGarvey, D-KY-3) H.R.6789 - To amend the Consumer Financial Protection Act of 2010 to clarify standards for UDAAP enforcement actions brought by the Bureau of Consumer Financial Protection, and for other purposes. (Andy Barr, R-KY-6) S.3502 - To amend the Fair Credit Reporting Act to prevent consumer reporting agencies from furnishing consumer reports under certain circumstances, and for other purposes. (Jack Reed, D-RI) S.3554 - To amend the Financial Stability Act of 2010 to provide the Financial Stability Oversight Council with duties regarding artificial intelligence in the financial sector, and for other purposes. (Mark Warner, D-VA) H.R.6962 - To place the Financial Stability Oversight Council and the Office of Financial Research under the regular appropriations process, to provide for certain quarterly reporting and public notice and comment requirements for the Office of Financial Research, and for other purposes. (Tom Emmer, R-MN-6) S.3601 - A bill to amend the Financial Stability Act of 2010 to require the Financial Stability Oversight Council to consider alternative approaches before determining that a U.S. nonbank financial company shall be supervised by the Board of Governors of the Federal Reserve System, and for other purposes. (Mike Rounds, R-SD) H.R.7531 - To require the Board of Governors of the Federal Reserve System to study the impacts of the Board's Reg II proposed rule, to complete a quantitative impact analysis of such rule, and to consider the results of such study and analysis before finalizing such rule, and for other purposes. (Blaine Luetkemeyer, R-MO-3) H.R.7625 - To require the Board of Governors of the Federal Reserve System and the Securities and Exchange Commission to issue an annual report to Congress projecting and accounting for the economic costs directly and indirectly caused by the impacts of climate change, to require the Federal Retirement Thrift Investment Board to establish a Federal Advisory Panel on the Economics of Climate Change, and for other purposes. (Emanuel Cleaver, D-MO-5) Senate Version: S.3922 - A bill to require the Board of Governors of the Federal Reserve System and the Securities and Exchange Commission to issue an annual report to Congress projecting and accounting for the economic costs directly and indirectly caused by the impacts of climate change, to require the Federal Retirement Thrift Investment Board to establish a Federal Advisory Panel on the Economics of Climate Change, and for other purposes. (Jeff Merkley, D-OR) H.R.7780 - To amend the Internal Revenue Code of 1986 to prohibit certain retirement plans from making investment decisions on the basis of factors other than financial risk and return factors. (Greg Murphy, R-NC-3)

Client expense: $380,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.317 - To amend the Securities Exchange Act of 1934 to prohibit the Securities and Exchange Commission from requiring an issuer to make climate-related disclosures that are not material to investors, and for other purposes. (Stephanie Bice, R-OK-5) H.R.557 - To promote United States interests at the international financial institutions, and for other purposes. (French Hill, R-AR-2) S.391 - A bill to amend the Securities Exchange Act of 1934 to prohibit the Securities and Exchange Commission from requiring an issuer to disclose information relating to certain greenhouse gas emissions, and for other purposes. (John Boozman, R-AR) House Version: H.R.1018 - To amend the Securities Exchange Act of 1934 to prohibit the Securities and Exchange Commission from requiring an issuer to disclose information related to certain greenhouse gas emissions, and for other purposes. (Frank Lucas, R-OK-3) H.R.1165 - Data Privacy Act of 2023 (Patrick McHenry, R-NC-10) H.R.1313 - To enhance rulemaking requirements for the Bureau of Consumer Financial Protection, and for other purposes. (Alex Mooney, R-WV-2) H.R.1382 - To change the Bureau of Consumer Financial Protection into an independent agency named the Consumer Financial Empowerment Agency, to transition the Agency to the regular appropriations process, and for other purposes. (Andy Barr, R-KY-6) H.R.1410 - To amend the Consumer Financial Protection Act of 2010 to make the Bureau of Consumer Financial Protection an independent Consumer Financial Protection Commission, and for other purposes. (Blaine Luetkemeyer, R-MO-3) H.R.1411 - To require Senate confirmation of Inspector General of the Bureau of Consumer Financial Protection, and for other purposes. (Blaine Luetkemeyer, R-MO-3) H.R.1506 - To amend section 1003 of title 5, United States Code (commonly referred to as the Federal Advisory Committee Act), to prohibit the establishment of advisory committees related to environmental, social, and governance aspects. (Ronny Jackson, R-TX-13) S.915 - A bill to require Presidential appointment and Senate confirmation of the Inspector General of the Board of Governors of the Federal Reserve System and the Bureau of Consumer Financial Protection. (Rick Scott, R-FL) S.1160 - A bill to provide greater transparency with respect to the financial regulatory agencies, and for other purposes. (Thom Tillis, R-NC) H.R.2489 - To amend the Consumer Financial Protection Act of 2010 to update the purpose of the Bureau of Consumer Financial Protection, and for other purposes. (Tom Emmer, R-MN-6) H.R.2798 - CFPB Transparency and Accountability Reform Act (Andy Barr, R-KY-6) H.R.2937 - To eliminate the Bureau of Consumer Financial Protection. (Byron Donalds, R-FL-19) Senate Version: S.1363 - A bill to eliminate the Bureau of Consumer Financial Protection. (Ted Cruz, R-TX) H.R.3057 - To provide that under the securities laws certain disclosures related to scope 3 greenhouse-gas emissions may not be required. (Ronny Jackson, R-TX-13) S.1362 - A bill to amend the Consumer Financial Protection Act of 2010 to enhance rulemaking requirements for the Bureau of Consumer Financial Protection, and for other purposes. (John Kennedy, R-LA) H.R.3466 - To enhance Financial Stability Oversight Council transparency. (Andy Barr, R-KY-6) H.R.3812 - To amend the Financial Stability Act of 2010 to require the Financial Stability Oversight Council to consider alternative approaches before determining that a U.S. nonbank financial company shall be supervised by the Board of Governors of the Federal Reserve System, and for other purposes. (Bill Foster, D-IL-11) H.R.4206 - To amend the Financial Stability Act of 2010 to require covered financial institutions to include elements of accumulated other comprehensive income when calculating capital for purposes of meeting capital requirements, and for other purposes. (Brad Sherman, D-CA-32) H.R.4642 - To require transparency from the Federal financial regulators with respect to international meetings, negotiations, and agreements, and for other purposes. (Mike Flood, R-NE-1) S.2409 - A bill to limit purchases of the Federal reserve banks, to require Generally Accepted Accounting Principles standards, and for other purposes. (Rick Scott, R-FL) H.R.5993 - To amend the Consumer Financial Protection Act of 2010 to clarify the funding of the Bureau of Consumer Financial Protection, and for other purposes. (French Hill, R-AR-2) Senate Version: S.3095 - A bill to amend the Consumer Financial Protection Act of 2010 to clarify the funding of the Bureau of Consumer Financial Protection. (Bill Hagerty, R-TN) H.R.6486 - To establish the position of Coordinator for Community Financial Institutions within the Small Business Administration to enhance the performance of community financial institutions and support access to capital for small business concerns, and for other purposes. (Morgan McGarvey, D-KY-3) H.R.6789 - To amend the Consumer Financial Protection Act of 2010 to clarify standards for UDAAP enforcement actions brought by the Bureau of Consumer Financial Protection, and for other purposes. (Andy Barr, R-KY-6) S.3502 - To amend the Fair Credit Reporting Act to prevent consumer reporting agencies from furnishing consumer reports under certain circumstances, and for other purposes. (Jack Reed, D-RI) S.3554 - To amend the Financial Stability Act of 2010 to provide the Financial Stability Oversight Council with duties regarding artificial intelligence in the financial sector, and for other purposes. (Mark Warner, D-VA)

H.R.317 - To amend the Securities Exchange Act of 1934 to prohibit the Securities and Exchange Commission from requiring an issuer to make climate-related disclosures that are not material to investors, and for other purposes. (Stephanie Bice, R-OK-5) H.R.557 - To promote United States interests at the international financial institutions, and for other purposes. (French Hill, R-AR-2) S.391 - A bill to amend the Securities Exchange Act of 1934 to prohibit the Securities and Exchange Commission from requiring an issuer to disclose information relating to certain greenhouse gas emissions, and for other purposes. (John Boozman, R-AR) House Version: H.R.1018 - To amend the Securities Exchange Act of 1934 to prohibit the Securities and Exchange Commission from requiring an issuer to disclose information related to certain greenhouse gas emissions, and for other purposes. (Frank Lucas, R-OK-3) H.R.1165 - Data Privacy Act of 2023 (Patrick McHenry, R-NC-10) H.R.1313 - To enhance rulemaking requirements for the Bureau of Consumer Financial Protection, and for other purposes. (Alex Mooney, R-WV-2) H.R.1382 - To change the Bureau of Consumer Financial Protection into an independent agency named the Consumer Financial Empowerment Agency, to transition the Agency to the regular appropriations process, and for other purposes. (Andy Barr, R-KY-6) H.R.1410 - To amend the Consumer Financial Protection Act of 2010 to make the Bureau of Consumer Financial Protection an independent Consumer Financial Protection Commission, and for other purposes. (Blaine Luetkemeyer, R-MO-3) H.R.1411 - To require Senate confirmation of Inspector General of the Bureau of Consumer Financial Protection, and for other purposes. (Blaine Luetkemeyer, R-MO-3) H.R.1506 - To amend section 1003 of title 5, United States Code (commonly referred to as the Federal Advisory Committee Act), to prohibit the establishment of advisory committees related to environmental, social, and governance aspects. (Ronny Jackson, R-TX-13) S.915 - A bill to require Presidential appointment and Senate confirmation of the Inspector General of the Board of Governors of the Federal Reserve System and the Bureau of Consumer Financial Protection. (Rick Scott, R-FL) S.1160 - A bill to provide greater transparency with respect to the financial regulatory agencies, and for other purposes. (Thom Tillis, R-NC) H.R.2489 - To amend the Consumer Financial Protection Act of 2010 to update the purpose of the Bureau of Consumer Financial Protection, and for other purposes. (Tom Emmer, R-MN-6) H.R.2798 - CFPB Transparency and Accountability Reform Act (Andy Barr, R-KY-6) H.R.2937 - To eliminate the Bureau of Consumer Financial Protection. (Byron Donalds, R-FL-19) Senate Version: S.1363 - A bill to eliminate the Bureau of Consumer Financial Protection. (Ted Cruz, R-TX) H.R.3057 - To provide that under the securities laws certain disclosures related to scope 3 greenhouse-gas emissions may not be required. (Ronny Jackson, R-TX-13) S.1362 - A bill to amend the Consumer Financial Protection Act of 2010 to enhance rulemaking requirements for the Bureau of Consumer Financial Protection, and for other purposes. (John Kennedy, R-LA) H.R.3466 - To enhance Financial Stability Oversight Council transparency. (Andy Barr, R-KY-6) H.R.3812 - To amend the Financial Stability Act of 2010 to require the Financial Stability Oversight Council to consider alternative approaches before determining that a U.S. nonbank financial company shall be supervised by the Board of Governors of the Federal Reserve System, and for other purposes. (Bill Foster, D-IL-11) H.R.4206 - To amend the Financial Stability Act of 2010 to require covered financial institutions to include elements of accumulated other comprehensive income when calculating capital for purposes of meeting capital requirements, and for other purposes. (Brad Sherman, D-CA-32) H.R.4642 - To require transparency from the Federal financial regulators with respect to international meetings, negotiations, and agreements, and for other purposes. (Mike Flood, R-NE-1) S.2409 - A bill to limit purchases of the Federal reserve banks, to require Generally Accepted Accounting Principles standards, and for other purposes. (Rick Scott, R-FL)

H.R.317 - To amend the Securities Exchange Act of 1934 to prohibit the Securities and Exchange Commission from requiring an issuer to make climate-related disclosures that are not material to investors, and for other purposes. (Stephanie Bice, R-OK-5) H.R.557 - To promote United States interests at the international financial institutions, and for other purposes. (French Hill, R-AR-2) S.391 - A bill to amend the Securities Exchange Act of 1934 to prohibit the Securities and Exchange Commission from requiring an issuer to disclose information relating to certain greenhouse gas emissions, and for other purposes. (John Boozman, R-AR) House Version: H.R.1018 - To amend the Securities Exchange Act of 1934 to prohibit the Securities and Exchange Commission from requiring an issuer to disclose information related to certain greenhouse gas emissions, and for other purposes. (Frank Lucas, R-OK-3) H.R.1165 - Data Privacy Act of 2023 (Patrick McHenry, R-NC-10) H.R.1313 - To enhance rulemaking requirements for the Bureau of Consumer Financial Protection, and for other purposes. (Alex Mooney, R-WV-2) H.R.1382 - To change the Bureau of Consumer Financial Protection into an independent agency named the Consumer Financial Empowerment Agency, to transition the Agency to the regular appropriations process, and for other purposes. (Andy Barr, R-KY-6) H.R.1410 - To amend the Consumer Financial Protection Act of 2010 to make the Bureau of Consumer Financial Protection an independent Consumer Financial Protection Commission, and for other purposes. (Blaine Luetkemeyer, R-MO-3) H.R.1411 - To require Senate confirmation of Inspector General of the Bureau of Consumer Financial Protection, and for other purposes. (Blaine Luetkemeyer, R-MO-3) H.R.1506 - To amend section 1003 of title 5, United States Code (commonly referred to as the Federal Advisory Committee Act), to prohibit the establishment of advisory committees related to environmental, social, and governance aspects. (Ronny Jackson, R-TX-13) S.915 - A bill to require Presidential appointment and Senate confirmation of the Inspector General of the Board of Governors of the Federal Reserve System and the Bureau of Consumer Financial Protection. (Rick Scott, R-FL) S.1160 - A bill to provide greater transparency with respect to the financial regulatory agencies, and for other purposes. (Thom Tillis, R-NC) H.R.2489 - To amend the Consumer Financial Protection Act of 2010 to update the purpose of the Bureau of Consumer Financial Protection, and for other purposes. (Tom Emmer, R-MN-6) H.R.2798 - CFPB Transparency and Accountability Reform Act (Andy Barr, R-KY-6) H.R.2937 - To eliminate the Bureau of Consumer Financial Protection. (Byron Donalds, R-FL-19) Senate Version: S.1363 - A bill to eliminate the Bureau of Consumer Financial Protection. (Ted Cruz, R-TX) H.R.3057 - To provide that under the securities laws certain disclosures related to scope 3 greenhouse-gas emissions may not be required. (Ronny Jackson, R-TX-13) S.1362 - A bill to amend the Consumer Financial Protection Act of 2010 to enhance rulemaking requirements for the Bureau of Consumer Financial Protection, and for other purposes. (John Kennedy, R-LA) H.R.3466 - To enhance Financial Stability Oversight Council transparency. (Andy Barr, R-KY-6) H.R.3812 - To amend the Financial Stability Act of 2010 to require the Financial Stability Oversight Council to consider alternative approaches before determining that a U.S. nonbank financial company shall be supervised by the Board of Governors of the Federal Reserve System, and for other purposes. (Bill Foster, D-IL-11) H.R.4206 - To amend the Financial Stability Act of 2010 to require covered financial institutions to include elements of accumulated other comprehensive income when calculating capital for purposes of meeting capital requirements, and for other purposes. (Brad Sherman, D-CA-32)

HR 3057 - Household Product Labeling Act of 2009 S 1697 - Household Product Labeling Act of 2009 All sections particularly labeling of ingredients in cleaning products.

Client expense: $43,573 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Council on Environmental Quality (CEQ), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), SENATE

HR 3057 - Household Product Labeling Act of 2009 S 1697 - Household Product Labeling Act of 2009 All sections particularly labeling of ingredients in cleaning products.

Client expense: $12,310 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Council on Environmental Quality (CEQ), Environmental Protection Agency (EPA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Interior, Dept of (DOI), Office of Management & Budget (OMB), SENATE

Implementation of Consumer Product Safety Improvement Act (CPSIA) of 2008 S.1697 Household Product Labeling Act of 2009 HR.3057 Household Product labeling Act of 2009 Enhancements to the Consumer Product Safety Improvement Act

Client expense: $980,915 · Firm income: Not reported

Government targets: Bureau of Citizenship & Immigration Services (BCIS), Commerce, Dept of (DOC), Consumer Product Safety Commission (CPSC), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Communications Commission (FCC), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Intl Trade Administration (ITA), Justice, Dept of (DOJ), Natl Security Council (NSC), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Customs & Border Protection, U.S. Immigration & Customs Enforcement (ICE), U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)

Legislation in the 111th H.R. 1523, the Ban Poisonous Additives Act of 2009 (Senate version S. 593) The Breast Cancer Fund supports this legislation because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund has been meeting with staff from various offices to encourage co-sponsorship and eventual passage of this bill. Continued: Legislation in the 111th H.R. 2751, FDA Food Safety Modernization Act (Senate version S. 510) The Breast Cancer Fund supported efforts to pass this legislation because of a possible amendment to ban bisphenol-A, a chemical linked to increased rates of cancer, as well as other significant health problems, from certain food contact materials. The Breast Cancer Fund met with staff from various offices to encourage support for this language and eventual passage of the bill. House and Senate Appropriations The Breast Cancer Fund has been speaking with House and Senate offices about increasing federal funding for state biomonitoring programs through the CDC grants program as well as support for health tracking and NIEHS programs related to breast cancer research. H.R. 3057 Household Product Labeling Act of 2009 (Senate version S. 1697) The Breast Cancer Fund supports this legislation because complete and accurate product labeling of chemicals used in consumer products is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. H.R. 4190 Endocrine Disruption Prevention Act of 2009(Senate version S. 2828) The Breast Cancer Fund supports this legislation as it will increase the coordination and resources dedicated to research on endocrine disrupting substances, an important link to increased risk of lifetime incidence of breast cancer. H.R. 5820 The Safe Chemicals Act of 2010 (Senate version 3209) The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. H.R. 5786 Safe Cosmetics Act of 2010 (Senate version not yet introduced) The Breast Cancer Fund supports this legislation to reform the FDAs regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from various Senate offices to draft legislation to reform the FDAs regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), The Breast Cancer Fund has also met with Deputy Commissioner Josh Sharfstein and additional members of the FDA management team concerning the FDAs ongoing review of BPA, upcoming cosmetics legislation, and the FDAs transparency policies more generally. Presidents Cancer Panel Report The Breast Cancer Fund provided educational briefings to staff within the Executive Office of the President and the Office of Science and Technology Policy regarding the report and recommendations of the Presidents Cancer Panel. P.L. 110-314 The Consumer Product Safety Commission Improvement Act This law has broadly reformed and modernized the Consumer Product Safety Commission. The Breast Cancer Fund lobbied in support of a Feinstein amendment in the Senate and in conference negotiations which inserts phthalates as a banned substance in the manufacture of childrens toys. We are now monitoring implementation of this law: calling on the Executive Branch to nominate a new Chair for the agency and submitting public comments on various stages of implementation. P.L. 110-354 -- Breast Cancer and Environmental Research Act of 2008 This law authorizes the Director of the National Institute of Environmental Health Sciences to make grants for the development and operation of research centers regarding environmental factors that may be related to the etiology of breast cancer. The Breast Cancer Fund was not actively involved in passage of the bill apart from coalition support but has since met with authors to discuss implementation and the appointment process to the community panel that will oversee the grant process.

H.R. 3057 and S. 1697 product ingredient communication and product safety issues

Client expense: $111,000 · Firm income: Not reported

Government targets: Consumer Product Safety Commission (CPSC), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE

H.R. 2997, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2010 H.R. 2868, Chemical Facility Anti-Terrorism Act of 2009 H.R. 5320, Assistance Quality and Affordability Act of 2010 H.R. 2996, Department of Interior, Environment, and Related Agencies Act of 2010 H.R. 5820, Toxic Chemicals Safety Act of 2010 H.R. 6087, To amend the Federal Insecticide, Fungicide, and Rodenticide Act to improve the use of certain registered pesticides H.R. 4678, Foreign Manufacturers Legal Accountability Act of 2010 H.R. 6273, To amend the Federal Insecticide, Fungicide, and Rodenticide Act to exempt the application of pesticides subject to that Act, when applied in conformance with that Act, from certain permit requirements under the Federal Water Pollution Control Act, and for other purposes H.R. 4190, Endocrine Disruption Prevention Act of 2009 H.R. 5088, America's Commitment to Clean Water Act H.R. 2892, Patent Reform Act of 2009 H.R. 3202, Water Protection and Reinvestment Act of 2009 H.R. 3057, Product "Household" Labeling Act of 2009 H.R. 2454, American Clean Energy and Security Act of 2009 H.R. 5509, Chesapeake Bay Program Reauthorization and Improvement Act S. 1816, Chesapeake Clean Water and Ecosystem Restoration Act S. 1868, The Chesapeake Clean Water and Ecosystem Act of 2009 S. 519, POPs, LRTAP POPs, and Pic Implementation Act of 2009 S. 515, Patent Reform Act of 2009 S. 787, Clean Water Restoration Act S. 1406, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2010 S. 1298, Department of Homeland Security Appropriations Act of 2010 S. 2828, Endocrine Disruption Prevention Act of 2009 S. 510, FDA Food Safety Modernization Act of 2009 S. 2996, Continuing Chemical Facilities Antiterrorism Security Act of 2010 S. 3209, The Safe Chemicals Act of 2010 S. 3735, A bill to amend the Federal Insecticide, Fungicide, and Rodenticide Act to improve the use of certain registered pesticides S. 3861, Strengthening Protection for Children and Communities from Disease Clusters Act S. 3834, Representation for Farmers Act

HR 759 - FDA Globalization Act - Title III - cosmetics Safety of cosmetic/personal care/household cleaning products & ingredients HR 3057 & HR 1697 - ingredient disclosure - consumer products Foreign Manufacturers Legal Act - H.R. 4678 & S. 1606

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Implementation of Consumer Product Safety Improvement Act (CPSIA) of 2008 S.1697 Household Product Labeling Act of 2009 HR.3057 Household Product labeling Act of 2009 Enhancements to the Consumer Product Safety Improvement Act

Client expense: $1,030,211 · Firm income: Not reported

Government targets: Bureau of Citizenship & Immigration Services (BCIS), Commerce, Dept of (DOC), Consumer Product Safety Commission (CPSC), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Communications Commission (FCC), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Homeland Security, Dept of (DHS), Intl Trade Administration (ITA), Justice, Dept of (DOJ), Natl Security Council (NSC), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Customs & Border Protection, U.S. Immigration & Customs Enforcement (ICE), U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)

Legislation in the 111th H.R. 1523, the Ban Poisonous Additives Act of 2009 (Senate version S. 593) The Breast Cancer Fund supports this legislation because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund has been meeting with staff from various offices to encourage co-sponsorship and eventual passage of this bill. Continued: Legislation in the 111th House and Senate Appropriations The Breast Cancer Fund has been speaking with House and Senate offices about increasing federal funding for state biomonitoring programs through the CDC grants program as well as support for health tracking and NIEHS programs related to breast cancer research. H.R. 3057 Household Product Labeling Act of 2009 (Senate version S. 1697) The Breast Cancer Fund supports this legislation because complete and accurate product labeling of chemicals used in consumer products is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. H.R. 4190 Endocrine Disruption Prevention Act of 2009(Senate version S. 2828) The Breast Cancer Fund supports this legislation as it will increase the coordination and resources dedicated to research on endocrine disrupting substances, an important link to increased risk of lifetime incidence of breast cancer. H.R. 5820 The Safe Chemicals Act of 2010 (Senate version 3209) The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products. H.R. 5786 Safe Cosmetics Act of 2010 (Senate version not yet introduced) The Breast Cancer Fund supports this legislation to reform the FDAs regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from various Senate offices to draft legislation to reform the FDAs regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), The Breast Cancer Fund has also met with Deputy Commissioner Josh Sharfstein and additional members of the FDA management team concerning the FDAs ongoing review of BPA, upcoming cosmetics legislation, and the FDAs transparency policies more generally. Presidents Cancer Panel Report The Breast Cancer Fund provided educational briefings to staff within the Executive Office of the President and the Office of Science and Technology Policy regarding the report and recommendations of the Presidents Cancer Panel. P.L. 110-314 The Consumer Product Safety Commission Improvement Act This law has broadly reformed and modernized the Consumer Product Safety Commission. The Breast Cancer Fund lobbied in support of a Feinstein amendment in the Senate and in conference negotiations which inserts phthalates as a banned substance in the manufacture of childrens toys. We are now monitoring implementation of this law: calling on the Executive Branch to nominate a new Chair for the agency and submitting public comments on various stages of implementation. P.L. 110-354 -- Breast Cancer and Environmental Research Act of 2008 This law authorizes the Director of the National Institute of Environmental Health Sciences to make grants for the development and operation of research centers regarding environmental factors that may be related to the etiology of breast cancer. The Breast Cancer Fund was not actively involved in passage of the bill apart from coalition support but has since met with authors to discuss implementation and the appointment process to the community panel that will oversee the grant process.

H.R. 759 - FDA Globalization Act - Title III - Cosmetics Safety of cosmetic/personal care/household cleaning products & ingredients H.R. 3057 & H.R. 1697 - Ingredient disclosure - consumer products Foreign Manufacturers Legal Act - H.R. 4678 & S. 1606

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 2997, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2010 H.R. 2868, Chemical Facility Anti-Terrorism Act of 2009 H.R. 5320, Assistance Quality and Affordability Act of 2010 H.R. 2996, Department of Interior, Environment, and Related Agencies Act 2010 H.R. 5820, Toxic Chemicals Safety Act of 2010 H.R. 6087, To amend the Federal Insecticide, Fungicide, and Rodenticide Act to improve the use of certain registered pesticides H.R. 4678, Foreign Manufacturers Legal Accountability Act of 2010 H.R. 6273, To amend the Federal Insecticide, Fungicide, and Rodenticide Act to exempt the application of pesticides subject to that Act, when applied in conformance with that Act, from certain permit requirements under the Federal Water Pollution Control Act, and for other purposes H.R. 4190, Endocrine Disruption Prevention Act of 2009 H.R. 5088, America's Commitment to Clean Water Act H.R. 2892, Patent Reform Act of 2009 H.R. 3202, Water Protection and Reinvestment Act of 2009 H.R. 3057, Product "Household" Labeling Act of 2009 H.R. 2454, American Clean Energy and Security Act of 2009 S. 1868, The Chesapeake Clean Water and Ecosystem Act of 2009 S. 519, POPs, LRTAP POPs, and Pic Implementation Act of 2009 S. 515, Patent Reform Act of 2009 S. 787, Clean Water Restoration Act S. 1406, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2010 S. 1298, Department of Homeland Security Appropriations Act 2010 S. 2828, Endocrine Disruption Prevention Act of 2009 S. 510, FDA Food Safety Modernization Act of 2009 S. 2996, Continuing Chemical Facilities Antiterrorism Security Act of 2010 S. 3209, The Safe Chemicals Act of 2010 S. 3735, A bill to amend the Federal Insecticide, Fungicide, and Rodenticide Act to improve the use of certain registered pesticides S. 3861, Strengthening Protection for Children and Communities From Disease Clusters Act S. 3834, Representation for Farmers Act

H.R. 3057 and S. 1697, product ingredient communication and product safety issues

Client expense: $140,000 · Firm income: Not reported

Government targets: Consumer Product Safety Commission (CPSC), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE

Legislation in the 111th H.R. 1523, the Ban Poisonous Additives Act of 2009 (Senate version S. 593) Continued: Legislation in the 111th H.R. 1523, the Ban Poisonous Additives Act of 2009 (Senate version S. 593) The Breast Cancer Fund supports this legislation because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund has been meeting with staff from various offices to encourage co-sponsorship and eventual passage of this bill. House and Senate Appropriations The Breast Cancer Fund has been speaking with House and Senate offices about increasing federal funding for state biomonitoring programs through the CDC grants program as well as support for health tracking and NIEHS programs related to breast cancer research. H.R. 3057 Household Product Labeling Act of 2009 (Senate version S. 1697) The Breast Cancer Fund supports this legislation because complete and accurate product labeling of chemicals used in consumer products is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. H.R. 4190 Endocrine Disruption Prevention Act of 2009(Senate version S. 2828) The Breast Cancer Fund supports this legislation as it will increase the coordination and resources dedicated to research on endocrine disrupting substances, an important link to increased risk of lifetime incidence of breast cancer. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from various House and Senate offices to draft legislation to reform the FDAs regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. The Breast Cancer Fund has met with staff from various House and Senate offices about future legislation to reform the Estrogenic Substances Screening Program at EPA with the goal of identifying and removing estrogenic compounds in our nations drinking supply that currently increase the risk of breast cancer incidence. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), The Breast Cancer Fund has also met with Deputy Commissioner Josh Sharfstein and additional members of the FDA management team concerning the FDAs ongoing review of BPA, upcoming cosmetics legislation, and the FDAs transparency policies more generally. P.L. 110-314 The Consumer Product Safety Commission Improvement Act This law has broadly reformed and modernized the Consumer Product Safety Commission. The Breast Cancer Fund lobbied in support of a Feinstein amendment in the Senate and in conference negotiations which inserts phthalates as a banned substance in the manufacture of childrens toys. We are now monitoring implementation of this law: calling on the Executive Branch to nominate a new Chair for the agency and submitting public comments on various stages of implementation. P.L. 110-354 -- Breast Cancer and Environmental Research Act of 2008 This law authorizes the Director of the National Institute of Environmental Health Sciences to make grants for the development and operation of research centers regarding environmental factors that may be related to the etiology of breast cancer. The Breast Cancer Fund was not actively involved in passage of the bill apart from coalition support but has since met with authors to discuss implementation and the appointment process to the community panel that will oversee the grant process. S.3209, the Safe Chemicals Act of 2010 (House bill not yet introduced). The Breast Cancer Fund supports this legislation because it would mandate the testing of chemicals for their health risks, including potentially hazardous, cancer-causing chemicals currently being used in a variety of consumer products.

H.R. 759 - FDA Globalization Act - Title III - Cosmetics Safety of cosmetic/personal care/household cleaning products & ingredients H.R. 3057 & H.R. 1697 - Ingredient disclosure - consumer products Foreign Manufacturers Legal Act - H.R. 4678 & S. 1606

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Implementation of Consumer Product Safety Improvement Act (CPSIA) of 2008 S.1697 Household Product Labeling Act of 2009 HR.3057 Household Product labeling Act of 2009 Enhancements to the Consumer Product Safety Improvement Act

Client expense: $1,079,067 · Firm income: Not reported

Government targets: Bureau of Citizenship & Immigration Services (BCIS), Commerce, Dept of (DOC), Consumer Product Safety Commission (CPSC), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Communications Commission (FCC), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Intl Trade Administration (ITA), Justice, Dept of (DOJ), Natl Security Council (NSC), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Customs & Border Protection, U.S. Immigration & Customs Enforcement (ICE), U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)

H.R. 3057 & S. 1697 product ingredient communication and product safety issues

Client expense: $190,000 · Firm income: Not reported

Government targets: Consumer Product Safety Commission (CPSC), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE

H.R. 2997, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2010 H.R. 2868, Chemical and Water Security Act of 2009 H.R. 5320, Assistance Quality and Affordability Act of 2010 H.R. 2996, Department of Interior, Environment, and Related Agencies Appropriations Act 2010 H.R. 5088, America's Commitment to Clean Water Act H.R. 2892, Patent Reform Act of 2009 H.R. 3202, Water Protection and Reinvestment Act of 2009 H.R. 3057, Product "Household" Labeling Act of 2009 H.R. 2454, American Clean Energy and Security Act of 2009 S. 1868, The Chesapeake Clean Water and Ecosystem Act of 2009 S. 519, POPs, LRTAP, POPs, and Pic Implementation Act of 2009 S. 515, Patent Reform Act of 2009 S. 787, Clean Water Restoration Act S. 1406, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2010 S. 1298, Department of Homeland Security Appropriations Act 2010 S. 2828, Endocrine Disruption Prevention Act of 2009 S. 510, FDA Food Safety Modernization Act of 2009 S. 2996, Continuing Chemical Facilities Antiterrorism Security Act of 2010 S. 3209, The Safe Chemicals Act of 2010

Client expense: $484,916 · Firm income: Not reported

Legislation in the 111th H.R. 1523, the Ban Poisonous Additives Act of 2009 (Senate version S. 593) Continued: Legislation in the 111th H.R. 1523, the Ban Poisonous Additives Act of 2009 (Senate version S. 593) The Breast Cancer Fund supports this legislation because bisphenol-A has been linked to increased rates of cancer, as well as other significant health problems. The Breast Cancer Fund has been meeting with staff from various offices to encourage co-sponsorship and eventual passage of this bill. House and Senate Appropriations The Breast Cancer Fund has been speaking with House and Senate offices about increasing federal funding for state biomonitoring programs through the CDC grants program as well as support for health tracking and NIEHS programs related to breast cancer research. H.R. 3057 Household Product Labeling Act of 2009 (Senate version S. 1697) The Breast Cancer Fund supports this legislation because complete and accurate product labeling of chemicals used in consumer products is a critical step in removing carcinogenic, and otherwise hazardous, materials from consumer products. H.R. 4190 Endocrine Disruption Prevention Act of 2009(Senate version S. 2828) The Breast Cancer Fund supports this legislation as it will increase the coordination and resources dedicated to research on endocrine disrupting substances, an important link to increased risk of lifetime incidence of breast cancer. Future Legislative Proposals: The Breast Cancer Fund continues to meet with staff from various House and Senate offices to draft legislation to reform the FDAs regulation of cosmetic ingredients based on mounting evidence that several ingredients of common cosmetic products have been linked to negative environmental health impacts, including breast cancer. The Breast Cancer Fund has met with staff from various House and Senate offices about future legislation to reform the Estrogenic Substances Screening Program at EPA with the goal of identifying and removing estrogenic compounds in our nations drinking supply that currently increase the risk of breast cancer incidence. Regulation and Legislative Intent: FDA Advocacy In addition to meeting with Congressional staff on the matter of bisphenol-A (BPA), The Breast Cancer Fund has also met with Deputy Commissioner Josh Sharfstein and additional members of the FDA management team concerning the FDAs ongoing review of BPA, upcoming cosmetics legislation, and the FDAs transparency policies more generally. P.L. 110-314 The Consumer Product Safety Commission Improvement Act This law has broadly reformed and modernized the Consumer Product Safety Commission. The Breast Cancer Fund lobbied in support of a Feinstein amendment in the Senate and in conference negotiations which inserts phthalates as a banned substance in the manufacture of childrens toys. We are now monitoring implementation of this law: calling on the Executive Branch to nominate a new Chair for the agency and submitting public comments on various stages of implementation. P.L. 110-354 -- Breast Cancer and Environmental Research Act of 2008 This law authorizes the Director of the National Institute of Environmental Health Sciences to make grants for the development and operation of research centers regarding environmental factors that may be related to the etiology of breast cancer. The Breast Cancer Fund was not actively involved in passage of the bill apart from coalition support but has since met with authors to discuss implementation and the appointment process to the community panel that will oversee the grant process.

H.R. 2997, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2010 H.R. 2868, Chemical and Water Security Act of 2009 H.R. 4190, The Endocrine Disruption Prevention Act of 2009 H.R. 2996, Department of Interior, Environment, and Related Agencies Appropriations Act 2010 H.R. 2892, Department of Homeland Security Appropriations Act 2010 H.R. 1260, Patent Reform Act of 2009 H.R. 3202, Water Protection and Reinvestment Act of 2009 H.R. 3057, Product "Household" Labeling Act of 2009 H.R. 2454, American Clean Energy and Security Act of 2009 S. 519, POPs, LRTAP, POPs, and PIC Implementation Act of 2009 S. 515, Patent Reform Act of 2009 S. 787, Clean Water Restoration Act S. 1406, Atriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2010 S. 1298, Department of Homeland Security Appropriations Act 2010 S. 2828, Endocrine Disruption Prevention Act of 2009 S. 510, FDA Food Safety Modernization Act of 2009 S. 2996, Continuing Chemical Facilities Antiterrorism Security Act of 2010

Client expense: $519,731 · Firm income: Not reported

Implementation of Consumer Product Safety Improvement Act (CPSIA) of 2008 S.1697 Household Product Labeling Act of 2009 HR.3057 Household Product labeling Act of 2009 Enhancements to the Consumer Product Safety Improvement Act

Client expense: $1,046,127 · Firm income: Not reported

Government targets: Bureau of Citizenship & Immigration Services (BCIS), Commerce, Dept of (DOC), Consumer Product Safety Commission (CPSC), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Communications Commission (FCC), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Intl Trade Administration (ITA), Justice, Dept of (DOJ), Natl Security Council (NSC), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Customs & Border Protection, U.S. Immigration & Customs Enforcement (ICE), U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)

H.R. 759 - FDA Globalization Act - Title III - Cosmetics Safety of cosmetic/personal care/household cleaning products & ingredients H.R. 3057 & H.R. 1697 - Ingredient Disclosure - Consumer Products

Client expense: Not reported · Firm income: $10,000

Government targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE

H.R. 2868, Chemical Facilty Anti-Terrorism ACt of 2009 H.R. 3057, S. 1697, Ingredient Disclosure legislation Proposed legislation on reform of the Toxic Substances Control Act and on endocrine disruption

Client expense: $290,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)

H.R. 3057 & S. 1697 product ingredient communication and product safety issues

Client expense: $100,000 · Firm income: Not reported

Government targets: Agriculture, Dept of (USDA), Consumer Product Safety Commission (CPSC), Energy, Dept of, Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE

Implementation of Consumer Product Safety Improvement Act (CPSIA) of 2008 S.1697 Household Product Labeling Act of 2009 HR.3057 Household Product labeling Act of 2009

Client expense: $824,821 · Firm income: Not reported

Government targets: Bureau of Citizenship & Immigration Services (BCIS), Commerce, Dept of (DOC), Consumer Product Safety Commission (CPSC), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Communications Commission (FCC), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Intl Trade Administration (ITA), Justice, Dept of (DOJ), Natl Security Council (NSC), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Customs & Border Protection, U.S. Immigration & Customs Enforcement (ICE), U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)

H.R. 2997, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2010 H.R. 2868, Chemical and Water Security Act of 2009 H.R. 4190, The Endocrine Disruption Prevention Act of 2009 S. 519, POPs, LRTAP POPs, and PIC Implementation Act of 2009 S. 515, Patent Reform Act of 2009 S. 787, Clean Water Restoration Act S. 1406, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Apporpriations Act, 2010 H.R. 2996, Department of Interior, Environment, and Related Agencies Appropriations Act 2010 H.R. 2892, Department of Homeland Security Appropriations Act 2010 S. 1298, Department of Homeland Security Appropriations Act 2010 H.R. 1260, Patent Reform Act of 2009 H.R. 3202, Water Protection and Reinvestment Act of 2009 H.R. 3057, Product "Household" Labeling Act of 2009 H.R. 2454, American Clean Energy and Security Act of 2009 S. 2828, Endocrine Disruption Prevention Act of 2009 S. 510, FDA Food Safety Modernization Act of 2009

Client expense: $474,161 · Firm income: Not reported

H.R. 759 - FDA Globalization Act - Title III - Cosmetics Safety of cosmetic/personal care/household cleaning products H.R. 3057 & H.R. 1697 - Ingredient disclosure consumer products

Client expense: Not reported · Firm income: $10,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Chemicals Management, including potential reform of the Toxic Substances Control Act. No specific legislation introduced as of yet. Bills introduced on ingredient disclosure, S. 1697 and H.R. 3057

Client expense: $330,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 3057 & S. 1697 product ingredient and consumer product safety issues

Client expense: $70,000 · Firm income: Not reported

Government targets: Consumer Product Safety Commission (CPSC), Council on Environmental Quality (CEQ), Environmental Protection Agency (EPA), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, White House Office

H.R. 3057 & S. 1697 product ingredient communication and consumer product safety issues

Client expense: $100,000 · Firm income: Not reported

Government targets: Consumer Product Safety Commission (CPSC), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE, White House Office

H.R. 3057 & S. 1697, product ingredient communication and consumer product safety issues

Client expense: $100,000 · Firm income: Not reported

Government targets: Consumer Product Safety Commission (CPSC), Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE, White House Office

Implementation of Consumer Product Safety Improvement Act (CPSIA) of 2008 S.1697 Household Product Labeling Act of 2009 HR.3057 Household Product labeling Act of 2009

Client expense: $1,209,750 · Firm income: Not reported

Government targets: Bureau of Citizenship & Immigration Services (BCIS), Commerce, Dept of (DOC), Consumer Product Safety Commission (CPSC), Energy, Dept of, Environmental Protection Agency (EPA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), Intl Trade Administration (ITA), Justice, Dept of (DOJ), Natl Security Council (NSC), Office of Science & Technology Policy (OSTP), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Agency for International Development (USAID), U.S. Customs & Border Protection, U.S. Immigration & Customs Enforcement (ICE), U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)

H.R. 1256, Family Smoking Prevention and Tobacco Control Act H.R. 2997, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Apporpriations Act of 2010 H.R. 2749, Food Safety Enhancement Act of 2009 H.R. 2868, The Chemical Facility Antiterrorism Act of 2009 S. 519, POPs, LRTAP POPs, and PIC Implementation Act of 2009 S. 515, Patent Reform Act of 2009 S. 787, Clean Water Restoration Act S. 982, Family Smoking Prevention and Tobacco Control Act S. 1406, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2010 H.R. 2996, Department of Interior, Environment, and Related Agencies Appropriations Act 2010 H.R. 2892, Department of Homeland Security Apporpriations Act, 2010 S. 1298, Department of Homeland Security Appropriations Act, 2010 H.R. 1260, Patent Reform Act of 2009 H.R. 3202, Water Protection and Reinvestment Act of 2009 H.R. 3057, Product "Household" Labeling Act of 2009 H.R. 2454, American Clean Energy and Security Act of 2009

Client expense: $474,161 · Firm income: Not reported

H.R. 759 FDA Globalization Act - Title III - Cosmetics Safety of cosmetic/personal care/household cleaning products H.R. 3057 & HR 1697 - Ingredient disclosure consumer products

Client expense: Not reported · Firm income: $10,000

Government targets: Environmental Protection Agency (EPA), HOUSE OF REPRESENTATIVES, SENATE

H.R. 3057 & S. 1697, product ingredient communication and consumer product safety issues

Client expense: $70,000 · Firm income: Not reported

Government targets: Consumer Product Safety Commission (CPSC), Council on Environmental Quality (CEQ), Environmental Protection Agency (EPA), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE, White House Office

H.R. 3057 & P.L. 110-314; product ingredient communication and consumer product safety issues

Client expense: $120,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE